Actively Recruiting
Evaluation of Umbilical Cord Amniotic Membrane Implant in Surgery for Trapeziometacarpal Osteoarthritis to Improve Thumb Function and Reduce Pain
Led by TBF Genie Tissulaire · Updated on 2026-10-06
22
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of a human umbilical cord amniotic membrane allograft as an implant in the surgical treatment of trapeziometacarpal osteoarthritis, a condition causing pain and reduced function in the thumb joint. This Phase 2 study aims to determine if placing this amniotic membrane within the joint can reduce postoperative pain and improve thumb mobility, grip strength, pinch strength, and overall wrist function. Participants will undergo surgery on Day 0 where the treated, devitalized, and sterile umbilical cord amniotic membrane is placed as an interposition implant in the trapeziometacarpal joint. After surgery, participants will attend follow-up visits at 1 month, 3 months, 6 months, and 12 months to assess recovery and joint function. During the study, researchers will measure changes in thumb pain, mobility, and strength, as well as hand strength and wrist daily functionality compared to baseline. They will also monitor the progression of osteoarthritis stage and record any post-surgical complications or implant tolerance issues. Participation includes scheduled assessments and follow-ups over a 12-month period to track these outcomes.
CONDITIONS
Brief Title
Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of Trapeziometacarpal Osteoarthritis
Research Team
L
Laurence BARNOUIN
J
Justine BOSC
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here